Effectiveness and safety of rituximab in systemic lupus erythematosus: A case series describing the experience of 2 centres Vicenç Juan Gómez; Irene Carrión-Barberá; Tarek Carlos Salman Monte; Asunción Acosta; Vicenç Torrente-Segarra; Jordi Monfort;

Safety of biologic and synthetic targeted therapies in patients with immune-mediated diseases: data from the BIOBADAGUAY registry Paloma de Abreu; Sonia Cabrera; Darwin Cordovilla; Lourdes Román; Cristina Brunengo; Patricia Melgarejo; Macarena Soto; Vannia Valinotti; Angelica Amarilla; Belem Acevedo; Alexis Pineda; Evelyn Leiva; Paola Pusineri; Sandra Consani; Mariela Zarza; Clyde Parodi; Zoilo Morel; Roger Rolón; Paola Jara; Raquel Aranda; Laura Martínez; Gabriela Ávila;

Investigating potential biomarkers and therapeutic targets for patients with systemic lupus erythematosus (SLE) and rheumatoid arthritis (RA) through the utilization of cytokine profiling Akhil Akhil; Rohit Bansal; Jyotsana Kaushal; Aman Sharma; Archana Bhatnagar;